Reviewing Bath & Body Works (BBWI) & The Competition

Bath & Body Works (NYSE:BBWIGet Free Report) is one of 27 public companies in the “Retail stores, not elsewhere classified” industry, but how does it weigh in compared to its peers? We will compare Bath & Body Works to related companies based on the strength of its dividends, earnings, institutional ownership, profitability, risk, analyst recommendations and valuation.

Institutional and Insider Ownership

95.1% of Bath & Body Works shares are held by institutional investors. Comparatively, 33.7% of shares of all “Retail stores, not elsewhere classified” companies are held by institutional investors. 0.3% of Bath & Body Works shares are held by insiders. Comparatively, 15.7% of shares of all “Retail stores, not elsewhere classified” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Dividends

Bath & Body Works pays an annual dividend of $0.80 per share and has a dividend yield of 2.1%. Bath & Body Works pays out 19.5% of its earnings in the form of a dividend. As a group, “Retail stores, not elsewhere classified” companies pay a dividend yield of 2.6% and pay out 28.5% of their earnings in the form of a dividend.

Volatility and Risk

Bath & Body Works has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Comparatively, Bath & Body Works’ peers have a beta of 0.89, indicating that their average share price is 11% less volatile than the S&P 500.

Profitability

This table compares Bath & Body Works and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bath & Body Works 12.43% -44.03% 14.45%
Bath & Body Works Competitors -21.34% -60.07% 0.73%

Valuation and Earnings

This table compares Bath & Body Works and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Bath & Body Works $7.43 billion $878.00 million 9.32
Bath & Body Works Competitors $8.12 billion $153.49 million -5.57

Bath & Body Works’ peers have higher revenue, but lower earnings than Bath & Body Works. Bath & Body Works is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of recent ratings and price targets for Bath & Body Works and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bath & Body Works 1 6 9 0 2.50
Bath & Body Works Competitors 95 875 1511 62 2.61

Bath & Body Works currently has a consensus target price of $42.50, suggesting a potential upside of 11.20%. As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 8.90%. Given Bath & Body Works’ higher probable upside, equities research analysts plainly believe Bath & Body Works is more favorable than its peers.

Summary

Bath & Body Works beats its peers on 9 of the 15 factors compared.

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.